Lunch Innovation Theater (Non-Accredited): FROM REAL-WORLD EVIDENCE TO ACTION: Embracing Long-Acting Injectables for the Management of Schizophrenia

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Leslie Citrome, MD, MPH; Josh Hamilton, DNP, APRN-BC, FAANP

This presentation is provided by Johnson & Johnson